JIC
COLL icon

Joel Isaacson & Co’s Collegium Pharmaceutical COLL Stock Holding History

Joel Isaacson & Co’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-610
Closed -$9K – 248
2016
Q4 		$9K Hold
610
– – ﹤0.01% 511
2016
Q3 		$12K Hold
610
– – ﹤0.01% 521
2016
Q2 		$7K Hold
610
– – ﹤0.01% 570
2016
Q1 		$11K Buy
+610
New +$11.1K ﹤0.01% 560

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Joel Isaacson & Co's COLL Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Collegium Pharmaceutical (COLL) in Q1 2017, closing a stake of 610 shares — an estimated $9K sold.

Joel Isaacson & Co first reported a position in COLL in Q1 2016 and held it in 4 quarters. The position peaked at $12K in Q3 2016. 83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

  • Joel Isaacson & Co reported no remaining Collegium Pharmaceutical position as of Q1 2017 after selling out during the quarter.
  • Joel Isaacson & Co sold 610 Collegium Pharmaceutical shares in Q1 2017, an estimated $9K.
  • Joel Isaacson & Co first reported a position in Collegium Pharmaceutical in Q1 2016 and held it in 4 quarters.
  • Joel Isaacson & Co's Collegium Pharmaceutical position peaked at $12K in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.